,dataset_name,cell_type,cell_type_ontology_id,donor_id,sex,race,development_stage,count,percentage
0,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",T cell,CL:0000084,SG_HEL_H230,female,Indian,49-year-old human stage,19,1.1979823455233292
1,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",platelet,CL:0000233,SG_HEL_H230,female,Indian,49-year-old human stage,4,0.25220680958385877
2,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",B cell,CL:0000236,SG_HEL_H230,female,Indian,49-year-old human stage,9,0.5674653215636822
3,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",monocyte,CL:0000576,SG_HEL_H230,female,Indian,49-year-old human stage,6,0.37831021437578816
4,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",natural killer cell,CL:0000623,SG_HEL_H230,female,Indian,49-year-old human stage,3,0.18915510718789408
5,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta T cell",CL:0000624,SG_HEL_H230,female,Indian,49-year-old human stage,26,1.639344262295082
6,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta T cell",CL:0000625,SG_HEL_H230,female,Indian,49-year-old human stage,5,0.31525851197982346
7,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mature B cell,CL:0000785,SG_HEL_H230,female,Indian,49-year-old human stage,5,0.31525851197982346
8,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",memory B cell,CL:0000787,SG_HEL_H230,female,Indian,49-year-old human stage,104,6.557377049180328
9,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",naive B cell,CL:0000788,SG_HEL_H230,female,Indian,49-year-old human stage,57,3.5939470365699875
10,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta cytotoxic T cell",CL:0000794,SG_HEL_H230,female,Indian,49-year-old human stage,127,8.007566204287516
11,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",gamma-delta T cell,CL:0000798,SG_HEL_H230,female,Indian,49-year-old human stage,14,0.8827238335435058
12,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",regulatory T cell,CL:0000815,SG_HEL_H230,female,Indian,49-year-old human stage,24,1.5132408575031526
13,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD4-positive, alpha-beta T cell",CL:0000895,SG_HEL_H230,female,Indian,49-year-old human stage,274,17.276166456494323
14,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD8-positive, alpha-beta T cell",CL:0000900,SG_HEL_H230,female,Indian,49-year-old human stage,136,8.575031525851198
15,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","central memory CD4-positive, alpha-beta T cell",CL:0000904,SG_HEL_H230,female,Indian,49-year-old human stage,218,13.745271122320302
16,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","effector memory CD4-positive, alpha-beta T cell",CL:0000905,SG_HEL_H230,female,Indian,49-year-old human stage,47,2.9634300126103406
17,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta memory T cell",CL:0000909,SG_HEL_H230,female,Indian,49-year-old human stage,59,3.720050441361917
18,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta cytotoxic T cell",CL:0000934,SG_HEL_H230,female,Indian,49-year-old human stage,5,0.31525851197982346
19,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-negative, CD56-bright natural killer cell, human",CL:0000938,SG_HEL_H230,female,Indian,49-year-old human stage,6,0.37831021437578816
20,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-positive, CD56-dim natural killer cell, human",CL:0000939,SG_HEL_H230,female,Indian,49-year-old human stage,112,7.0617906683480465
21,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mucosal invariant T cell,CL:0000940,SG_HEL_H230,female,Indian,49-year-old human stage,23,1.450189155107188
22,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD14-positive monocyte,CL:0001054,SG_HEL_H230,female,Indian,49-year-old human stage,245,15.447667087011348
23,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD14-low, CD16-positive monocyte",CL:0002396,SG_HEL_H230,female,Indian,49-year-old human stage,53,3.3417402269861283
24,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD1c-positive myeloid dendritic cell,CL:0002399,SG_HEL_H230,female,Indian,49-year-old human stage,5,0.31525851197982346
